Managing Cluster Headaches
Hours: 1.00
One of the most agonizing types of headache is the cluster headache. Cluster headaches are a neurovascular and chronobiological headache disorder. These headaches typically present with intense, strictly one-sided pain that can be orbital, supraorbital, temporal, or any combination of these. Most cluster headaches have a short duration, ranging from 15 to 180 minutes, and can occur as often as every other day to up to eight times a day. The episodic pattern is key to diagnosis, and the treatment of cluster headaches is usually drug therapy. For select patients with intractable headaches, a variety of neuromodulation procedures may help reduce or eliminate cluster headaches. The goal of this course is to provide pharmacists, pharmacy technicians, and physicians or providers in healthcare settings with information about the presentation, pathophysiology, and treatment of cluster headaches.
One of the most agonizing types of headache is the cluster headache. Cluster headaches are a neurovascular and chronobiological headache disorder. These headaches typically present with intense, strictly one-sided pain that can be orbital, supraorbital, temporal, or any combination of these. Most cluster headaches have a short duration, ranging from 15 to 180 minutes, and can occur as often as every other day to up to eight times a day. The episodic pattern is key to diagnosis, and the treatment of cluster headaches is usually drug therapy. For select patients with intractable headaches, a variety of neuromodulation procedures may help reduce or eliminate cluster headaches. The goal of this course is to provide pharmacists, pharmacy technicians, and physicians or providers in healthcare settings with information about the presentation, pathophysiology, and treatment of cluster headaches.
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 1.00 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Florida Board of Medicine
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
New Mexico Medical Board
Physicians will receive 1.00 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™
Michigan Board of Medicine
Physicians will receive 1.00 AMA PRA category 1 Credits™.
New Hampshire Medical Society
New Hampshire Medical Society (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-23-013-H01-P
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-23-013-H01-T
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.00 contact hours.
Michigan Board of Pharmacy
Michigan Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.00 contact hours.
Recall the epidemiology, pathology, various clinical features, and diagnostic criteria for cluster headaches.
Identify the abortive and prophylactic agents used to treat cluster headaches.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Understanding Cluster Headaches
Overview
Epidemiology
Pathophysiology
Section 3: Identifying Cluster Headaches
Presentation
Diagnosis
Section 4: Treating Cluster Headaches
Treatment
Acute Therapy
Prophylactic Therapy
Other Treatment Options
Neuromodulatory Treatments
Prognosis
Physical Exam
Section 5: Clinical Vignette
Meet Joel
Section 6: Conclusion
Summary
Course Contributors
Resources
References
Writer: Claire Hartman, RN, IBCLC
Subject Matter Expert: Johnny J. Bethea, II, RPhClaire Hartman, RN, BSN, IBCLC is a SME nurse writer for Relias in Acute Care. She has nursing experience in functional medicine, neonatal intensive care, and obstetrics. Ms. Hartman has over 10 years of experience in birth, with a focus on high-risk obstetrics and perinatal hospice. She is an Internationally Board Certified Lactation Consultant and has taught neonatal resuscitation, breastfeeding support, and routine gynecological care to providers in varied medical settings. Ms. Hartman has led a community support group for bereaved families experiencing perinatal loss.
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council.
The target audience for this course is: Pharmacists; Pharmacy Technicians; Physicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
